Baxter International Inc. (NYSE:BAX) announced today the publication of its sixth annual sustainability report, which captures the company's progress in 2004 related to economic, social and environmental performance.

Baxter's 2004 Sustainability Report Print Summary highlights the company's performance and is a companion piece to Baxter's sustainability website portal that provides information across a broad spectrum of indicators. The website also showcases case studies with additional perspective about how Baxter impacts and interacts with its communities and stakeholders, and convenient links to relevant company policies and guidelines. Baxter continues to align its online and print summary report to the Global Reporting Initiative (GRI) Guidelines, which provide a rigorous framework for reporting across the triple bottom line.

Baxter's 2004 Sustainability Report Summary can be viewed and ordered on its sustainability website portal at http://www.baxter.com/sustainability.

Baxter International Inc., through its subsidiaries, assists healthcare professionals and their patients with the treatment of complex medical conditions, including cancer, hemophilia, immune disorders, kidney disease and trauma. The company applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients' lives. For more information, please visit www.baxter.com.

Baxter International Inc.

Baxter International Inc.

At Baxter, sustainability means creating lasting social, environmental and economic value by addressing the needs of the company’s wide-ranging stakeholder base. The company's sustainability efforts support Baxter's mission to apply innovative science in the development of products and therapies that save and sustain patients' lives.

More from Baxter International Inc.